You Position: Home > Paper
优化免疫抑制方案,改善器官移植预后
( views:32, downloads:52 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Organ Transplantation
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.0254-1785.2019.05.101
- Key Word:
- No keyword available
Abstract： 近年来 ,随着供、受者选择标准的不断扩大 ,受者对免疫抑制剂的反应更加敏感 ,需要选择更为安全的免疫抑制方案.对于绝大多数器官移植受者 ,免疫抑制方案的疗效和安全性是影响预后的重要因素.优化免疫抑制方案有助于改善器官移植预后.
- [1]Charlotte,Defrancq,Nika,De Wilde,Ann,Raes,etc.Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes.[J].2019.
- [2]C H,Baek,C-D,Kim,D R,Lee,etc.Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids.[J].2019,51(3).
- [3]Sadollah, Abedini,Lasse, G?ransson,Elinor, Cockburn,etc.Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study.[J].2018,4(2).
- [4]Beckebaum S,Iacob S,Sweid D,etc.Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.[J].2011,24(7).
- [5]Armando,Torres,Domingo,Hernández,Francesc,Moreso,etc.Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus.[J].2018,3(6).
- [6]Thomas,Jouve,Johan,Noble,Lionel,Rostaing,etc.An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization.[J].2019,18(4).